MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO ...

Seasoned leader joins executive team to support global expansion and long-term value creationNEWTOWN, Pa., May 12, 2026 /PRNewswire/ -- Catalyx, a global leader in AI-powered machine vision ...

MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May ...

The DNA synthesis market is witnessing strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic ...

German media giant Bertelsmann plans to expand its music business significantly and merge its subsidiary BMG with the US ...

Alcami Corporation ("Alcami"), a leading U.S.-based contract development and manufacturing organization (CDMO), today announced the completion of the acquisition of Tjoapack, a leading global contract ...

Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

An overview of the validation and qualification requirements introduced in the 2022 EU GMP Annex 1 revision, with a focus on ...

Bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second-messenger molecule that is involved in the molecular decision between planktonic motile and sedentary ...

Review of environmental monitoring updates in the 2022 EU GMP Annex 1, including strategic contamination control.